Cargando…
Getting personal in metastatic melanoma: neoantigen-based vaccines as a new therapeutic strategy
Cancer vaccines are facing renewed interest, thanks to the progress recently achieved in the immunotherapy field, including the success of immune checkpoint inhibitors (CPIs). The advances in understanding the CPI mode of action revealed a central role of neoantigens for the outcome of such treatmen...
Autores principales: | D’Alise, Anna Morena, Scarselli, Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894148/ https://www.ncbi.nlm.nih.gov/pubmed/36721894 http://dx.doi.org/10.1097/CCO.0000000000000923 |
Ejemplares similares
-
Therapeutic cancer vaccination against telomerase: clinical developments in melanoma
por: Ellingsen, Espen Basmo, et al.
Publicado: (2023) -
Novel strategies to improve efficacy of treatment with tumor-infiltrating lymphocytes (TILs) for patients with solid cancers
por: Tas, Liselotte, et al.
Publicado: (2023) -
Intralesional therapy for advanced melanoma: promise and limitation
por: Agarwala, Sanjiv S.
Publicado: (2015) -
Development of encorafenib for BRAF-mutated advanced melanoma
por: Koelblinger, Peter, et al.
Publicado: (2018) -
Cutaneous angiosarcoma: update on biology and latest treatment
por: Ishida, Yoshihiro, et al.
Publicado: (2018)